Biovet has secured a license from CDSCO for Biolumpivaxin, the world's only marker vaccine for Lumpy Skin Disease in cattle ...

The firm has claimed that it is the first such vaccine in the world for the highly infectious viral disease that affects ...

The Central Drug Standards Control Organization (CDSCO) has granted a license to Biolumpivaxin, India’s first vaccine against ...

Biovet receives CDSCO license for LSD vaccine, a game-changer for animal health, developed in collaboration with ICAR.

Biovet, a subsidiary of the Bharat Biotech Group, has received approval from the CDSCO for its innovative LSD vaccine, ...

Biolumpivaxin will help in disease surveillance as it means the experts will be able to distinguish between vaccinated and naturally infected dairy cattle ...

Bharat Biotech's group company, Biovet, has launched the world's first-ever Lumpy Skin Disease (LSD) vaccine, Biolumpivaxin, ...

Get the latest on medical breakthroughs, disease outbreaks, public health news, and more shaping global health today. Stay ...

The Central Drug Standards Control Organization (CDSCO) has granted approval to Biolumpivaxin, India's first vaccine against ...

Biovet, a part of Bharat Biotech, on Monday said it has received approval from the Central Drug Standards Control ...

Biovet, a subsidiary of Bharat Biotech, has received approval from CDSCO for its lumpy skin disease vaccine, Biolumpvaxin, ...

The vaccine Biolumpivaxin, developed jointly by the Indian Council of Agricultural Research (ICAR) and Biovet, will enable ...